Long-term administration of hesperidin (HES) or glucosyl hesperidin (GHES), a water-soluble analogue of HES, brings about an antihypertensive effect on spontaneously hypertensive rats (SHR). In the present study, we investigated the effects of long-term admin istration of HES and GHES (corresponding to 30mg/d/kg body weight) on serum lipid con centration and morphology of vasculature. Serum HDL cholesterol increased in both SHR and Wistar-Kyoto rats (WKY) fed a HES-or GHES-containing diet for 25wk. Simulta neously, GHES administration reduced the vascular diameter and media-intimal cross-sec tional area of the abdominal aorta in SHR. These results suggest that HES as well as GHES improves serum cholesterol composition and that GHES inhibits hypertrophy in vasculature as well.
Hesperidin (HES) is known as an antioxidative fla vonoid contained in citrus fruits peal and glucosyl hes peridin (GHES) is made water-soluble by the addition of one glucose molecule to the HES molecule (1) . Our pre vious study has demonstrated that long-term adminis tration of HES and GHES has a beneficial effect of blood pressure reduction on spontaneously hypertensive rats (SHR) (2) .
Vascular smooth muscle cells (VSMCs) are one of the major constituents of blood vessel walls responsible for the maintenance of vessel structures and functions (3) . The migration and proliferation of VSMC have been considered to be key events in the development of hypertension-related atherosclerosis (4) . Increased vas cular resistance is a characteristic of arterial hyperten sion and results from functional and structural changes in resistance arteries (5) which accompany with the hypertrophy of vascular wall. Inversely, the elevation of blood pressure accelerates pathological hypertrophic changes of the vessels in hypertension (6) .
It has been often demonstrated that hypertension fol lows hyperlipidemia. Additionally, it has been noted that hypertension and hyperlipidemia are two of the major risk factors for atherosclerosis (7, 8) . Thus, im provement of hyperlipidemia or vessel hypertrophy may bring about a good effect on the hypertension.
The purpose of the present study is to investigate the changes in serum lipids composition and morphology of vasculature in SHR to which HES and GHES were admin istered for a long-term in comparison with those in WKY.
Materials and Methods Animals and diets. As described previously (2), 18 rats of 5wk old SHR and WKY (Charles River Japan, Kanagawa, Japan) were divided into 3 groups, which were fed for 25wk respective diets containing HES (30mg/d/kg body weight, Wako Pure Chemical Indus tries, Ltd., Osaka, Japan) or GHES (30mg/d/kg body weight, Toyo Sugar Refining Co., Ltd., Tokyo, Japan) and non-containing MF control (Oriental Yeast, Chiba, Japan). Total cholesterol, HDL cholesterol, total glycerol and non-esterified fatty acid (NEFA) levels in the serum were colorimetrically assayed by enzymatic procedures with commercial kits (Wako Pure Chemical Industries, Ltd.). Free glycerol was similarly assayed with a commercial kit (Roche Diagnostics, Basel, Switzerland) as well. Tri glyceride was calculated by subtracting the free glycerol from the total glycerol. LDL cholesterol was calculated by subtracting the HDL cholesterol and one fifth of tri glyceride from total cholesterol as usual (9) . 
Results
The consequences of weighing body mass, heart, kid ney and abdominal aorta are summarized in Table 1 . Although the weight of heart in control SHR was heavier than in control WKY as previously reported (10), such was also the case with the abdominal aorta. There was no significant difference between both con trol and HES or GHES-groups for 25 wk irrespective of SHR or WKY.
Serum HDL-cholesterol levels in HES-administered SHR were significantly higher than in control SHR. The ratio of HDL-cholesterol to total cholesterol in HES or GHES-administered SHR showed a significant increase as compared with that in the control. A similar ten dency was also observed in HES-administered WKY (Fig. 1) . The serum lipid parameters in SHR and WKY are summarized in Table 1 . Serum LDL-cholesterol level in HES-or GHES-administered rats tended to decrease, but the degree of lowering was not significant. Total cholesterol, triglyceride, free glycerol and free fatty acid were not altered by administration of HES or GHES in both SHR and WKY. in Fig. 2 . In addition, the results of their quantitative analyses are summarized in Table 2 . The morphological parameters thus obtained are as follows; vascular diam eter, media-intimal thickness, media-intimal cross-sec tional area and media-intimal cross-sectional area/ lumen area. Worthy of note, these parameters of the abdominal aorta were significantly larger in control SHR than in control WKY as previously described (11) . In the coronary artery, however, a significant difference between SHR and WKY was observed in the media-inti mal thickness alone, and not for other parameters. Administration of HES or GHES had no effect on any of the parameters of the coronary artery in SHR, while the vascular diameter and the media-intimal cross-sec tional area of the abdominal aorta significantly lessened in GHES-administered SHR relative to the control. In WKY, no morphological parameters were influenced by the administration of HES or GHES. It has been reported that short-term treatment of HES at a high dosage lowers total cholesterol, LDL, total lipid and triglyceride levels in normo-lipidaemic and dyslipidaemic Wistar rats but elevates HDL level in the same rats (18) . A mixture of HES and naringin also lowers plasma and hepatic cholesterol levels signi fi cantly (19) . This effect may be explained by partial inhi In practice, intraperitoneal administration of hesperetin-5-glucoside to rats fed a high fat diet signi fi cantly reduced the total cholesterol but had no effect on the serum triglyceride (20) . It seems likely that GHES as well as HES and other flavonoids participate in improve ment of serum cholesterol composition. Additionally we observed that the low dose of GHES reduced the vascular diameter and media-intimal cross sectional area of the abdominal aorta in SHR, where upon morphological data revealed vascular hypertro phy in SHR compared with WKY. Hypertension in human and experimental animals is often accompanied by vascular hypertrophy (21) . The hypertension in creases mecccanical stretch of blood vessels which ini tiates signaling pathways mediated by growth factors or growth regulatory molecules, and induces the prolifera tion of vascular smooth muscle cells (6) . Since elevated blood pressure may cause vascular hypertrophy, the antihypertrophic action of GHES may be the result of antihypertensive effect of GHES in SHR. Even so, the antihypertensive effect of HES was not accompanied by antihypertrophy. It is believed that both HES and GHES are metabolized into hesperetin in vivo. Since CITIES administration achieves higher hesperetin concentra tion in the plasma than HES administration (our unpublished observation), the difference in effective ness between HES and GHES may be explained by the plasma concentration of hesperetin. Further study is needed to clarify a correlation between antihyperten sion and antihypertrophy due to GHES administration.
It has been revealed by the present study that the long-term administration of HES as well as GHES at a low dose improves serum cholesterol composition and that GHES exerts a antihypertrophic effect on vascula ture at the same time.
